XML 62 R52.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS IN PRIVATE COMPANIES (Details Narrative)
$ in Thousands
3 Months Ended
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2020
USD ($)
Mar. 31, 2021
Jul. 11, 2019
USD ($)
shares
Aug. 31, 2015
shares
Series A preferred stock in Sentien Biotechnologies [Member]          
IfrsStatementLineItems [Line Items]          
Number of shares purchased         210,210
InvestmentOwnershipPercentage     5.06%    
Intensity [Member]          
IfrsStatementLineItems [Line Items]          
Unrealized Gain (Loss) On Investment | $   $ 1,600      
Intensity [Member] | Acquisition Of SalvaRx [Member]          
IfrsStatementLineItems [Line Items]          
Number of shares purchased 1,000,000.0        
InvestmentOwnershipPercentage 7.50%        
Unrealized Gain (Loss) On Investment | $ $ 700        
Intensity [Member] | Acquisition Of Intensity Holding Limited [Member]          
IfrsStatementLineItems [Line Items]          
Equity interests of acquirer | $       $ 1,300  
Number of instruments or interests issued or issuable       129,806  
Number Of Private Company Share Consists In Sole Asset       288,458  
Number of shares outstanding       1,288,458  
Percentage of voting equity interests acquired 8.00%